Zobrazeno 1 - 10
of 316
pro vyhledávání: '"immune Checkpoint inhibitor therapy"'
Autor:
Wanfen Tang, Chenghui Li, Dong Huang, Shishi Zhou, Hongjuan Zheng, Qinghua Wang, Xia Zhang, Jianfei Fu
Publikováno v:
Cancer Biology & Therapy, Vol 25, Iss 1 (2024)
To observe the antitumour efficacy of programmed death 1 (PD-1) inhibitors in the real world and explore the relationship between NRS2002 score or other clinical characteristics and immunotherapy efficacy, we retrospectively analyzed 341 tumor patien
Externí odkaz:
https://doaj.org/article/787fe12e25c04cdeabe6b1595d2cf6e9
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Immune checkpoint inhibitor therapy has dramatically improved survival in a significant subset of patients with several solid tumor types. Increasing the number of patients benefitting from this form of therapy is an important translational research
Externí odkaz:
https://doaj.org/article/1a48aff26a6740e6907bc8919e34c69b
Autor:
Porpáczy Adél, Lénárd László, Goják Ilona, Szukits Sándor, Kajtárné Papp Emőke, Komócsi András, Faludi Réka
Publikováno v:
Cardiologia Hungarica, Vol 54, Iss 3, Pp 222-226 (2024)
The use of immune checkpoint inhibitors (ICIs) is progressively broadening within oncology therapy. In parallel, as cardiologists, we anticipate an increasing incidence of cardiovascular immune-mediated complications, including myocarditis and perica
Externí odkaz:
https://doaj.org/article/e0f909c0aa924f97beef888b7d6d3ae6
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectivesAnalyzing the impact of peripheral lipid levels on the efficacy of immune checkpoint inhibitor therapy in non-small cell lung cancer (NSCLC) patient populations and exploring whether it can serve as a biomarker for broadening precise select
Externí odkaz:
https://doaj.org/article/ba016bf1eb4e4cbc880ec3b06ddaf38a
Autor:
Wilhite, Annelise M. a, ⁎, Wu, Sharon b, Xiu, Joanne b, Gibney, Geoffrey T. c, Phung, Thuy d, In, Gino K. e, Herzog, Thomas J. f, Khabele, Dineo g, Erickson, Britt K. h, Brown, Jubilee i, Rocconi, Rodney P. j, Pierce, Jennifer Y. a, Scalici, Jennifer M. a, Jones, Nathaniel L. a
Publikováno v:
In Gynecologic Oncology September 2024 188:13-21
Autor:
Aasha I. Hoogland, Andrew S. Brohl, Brent J. Small, Lauren Michael, Evan Wuthrick, Zeynep Eroglu, Dukagjin Blakaj, Claire Verschraegen, Nikhil I. Khushalani, Heather S. L. Jim, Sungjune Kim
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Merkel cell carcinoma is a rare skin cancer associated with poor survival. Based on a previous Phase II trial of adults with advanced Merkel cell carcinoma by Kim and colleagues (2022), there is now a strong rationale for combinat
Externí odkaz:
https://doaj.org/article/e3252975446043b48e54b4043aea4bb3
Publikováno v:
In Advances in Oncology May 2024 4(1):29-46
Autor:
Huang, Yi-Jung a, b, 1, Ho, Kai-Wen b, c, 1, Cheng, Tian-Lu b, d, Wang, Yen-Tseng a, b, c, Chao, Shi-Wei e, Huang, Bo-Cheng b, f, Chao, Yu-Shu e, Lin, Chia-Yu e, Hsu, Yun-Han b, e, Chen, Fang-Ming f, g, h, Chuang, Chih-Hung b, e, ⁎
Publikováno v:
In International Journal of Biological Macromolecules April 2024 265 Part 2
Autor:
Yanze Yin, Ao Zeng, Abudumijiti Abuduwayiti, Zhilong Xu, Keyi Chen, Chao Wang, Xinyun Fang, Jiarui Wang, Gening Jiang, Jie Dai
Publikováno v:
Cancer Medicine, Vol 13, Iss 6, Pp n/a-n/a (2024)
Abstract Background Patients with non‐small cell lung cancer (NSCLC) and chronic obstructive pulmonary disease (COPD) experience worse clinical outcomes but respond better to immunotherapy than patients with NSCLC without COPD. Mucosal‐associated
Externí odkaz:
https://doaj.org/article/8ec6727171b24c809882a2e678dabb03
Autor:
Wang, Jirong 1, Li, Xiaoran 1, Chen, Siyu, Cao, Jinlong, Fan, Xinpeng, Wang, Huabin, Zhang, Xingxing, Yang, Li ⁎
Publikováno v:
In Life Sciences 15 December 2023 335